Korkusuz Hüdayi, Sennert Michael, Fehre Niklas, Happel Christian, Grünwald Frank
Department of Nuclear Medicine, University Hospital Frankfurt , Frankfurt am Main , Germany.
Int J Hyperthermia. 2014 Nov;30(7):480-5. doi: 10.3109/02656736.2014.962626. Epub 2014 Oct 14.
The aim of this study was to assess whether high-intensity focused ultrasound (HIFU), a new and promising method for the treatment of benign hot and cold thyroid nodules using thermal ablation, has an impact on thyroid function, and to evaluate its feasibility in outpatient settings. Additionally, a possible difference in the treatment of solid and complex thyroid nodules was evaluated.
Ten patients with one thyroid nodule each (six cold and four hot nodules) underwent HIFU in January 2014. Four nodules were solid and six nodules were complex. Serum levels of triiodothyronine (T3), thyroxine (T4), thyrotropin (TSH), thyroglobulin (hTg) and additionally antibodies against hTg (TAK), TSH receptors (TRAK) and thyroid peroxidase (TPO) were measured at enrolment and 24 h after the HIFU treatment. The pre- and post-thyroglobulin reduction was measured to evaluate the scale of ablation. In addition, patients' pain was recorded on a numeric rating scale from 0 to 10.
The HIFU treatment did not affect thyroid function, since hormone levels stayed stable (p < 0.05). No serious immune reaction was induced. Thyroglobulin serum levels increased significantly (p < 0.05) and were correlated to the total energy emitted by HIFU (p < 0.1). The results of complex thyroid nodules did not differ from solid thyroid nodules. Similarly, the results of hot thyroid nodules did not differ from cold thyroid nodules. All patients tolerated the whole treatment and no severe complications were observed.
HIFU is a safe and effective method to treat benign, solid, complex, hot and cold thyroid nodules preserving thyroid function. Further developments of the system are needed to gain suitability for daily use.
本研究旨在评估高强度聚焦超声(HIFU)这种用于通过热消融治疗甲状腺良恶性结节的新的有前景的方法是否会对甲状腺功能产生影响,并评估其在门诊环境中的可行性。此外,还评估了实性和复杂性甲状腺结节治疗中的可能差异。
2014年1月,10例患者(每人有1个甲状腺结节,6个冷结节和4个热结节)接受了HIFU治疗。4个结节为实性,6个结节为复杂性。在入组时和HIFU治疗后24小时测量血清三碘甲状腺原氨酸(T3)、甲状腺素(T4)、促甲状腺激素(TSH)、甲状腺球蛋白(hTg)水平,另外还测量了抗hTg抗体(TAK)、TSH受体(TRAK)和甲状腺过氧化物酶(TPO)。测量甲状腺球蛋白治疗前后的降低情况以评估消融范围。此外,采用0至10的数字评分量表记录患者的疼痛程度。
HIFU治疗未影响甲状腺功能,因为激素水平保持稳定(p<0.05)。未诱发严重免疫反应。甲状腺球蛋白血清水平显著升高(p<0.05),且与HIFU发射的总能量相关(p<0.1)。复杂性甲状腺结节的结果与实性甲状腺结节无差异。同样,热结节的结果与冷结节无差异。所有患者均耐受整个治疗过程,未观察到严重并发症。
HIFU是一种安全有效的治疗甲状腺良恶性、实性、复杂性、热结节和冷结节且保留甲状腺功能的方法。需要对该系统进行进一步改进以使其适合日常使用。